Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; MNEXSPIKE (COVID-19 Vaccine, mRNA) | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-N-3447

Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; MNEXSPIKE (COVID-19 Vaccine, mRNA)

Documents

Comments

Description

Open

Documents

Type	Title	Posted	Comments	Status
Notice	Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; MNEXSPIKE (COVID–19 Vaccine, mRNA) FR Doc: 2026-07371	Apr 16, 2026	--	--

Keywords

CBER

FRDTS # 2026-63

Notice of Approval of Product Under Voucher:

Rare Pediatric Disease Priority Review Voucher

MNEXSPIKE (COVID-19 Vaccine, mRNA)

Open

Data from Regulations.gov